📰 Ognitive Function News
Page 33 - Ognitive Function News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ognitive Function. Real-time updates on events, politics, business and more.
September 8, 2023
Creatine supplementation can increase brain creatine content, which over time may help explain its promising effects on brain health and function, according to a recent review.
September 8, 2023
Clasado Biosciences, the developer of the prebiotic ingredient Bimuno galactooligosaccharides (GOS), is collaborating with scientists through a newly established scientific advisory board to further develop the future role of prebiotics within medical nutrition.
September 7, 2023
Exposure to an infant formula mimicking human milk lipid composition and milk fat globule structure positively affects child neurocognitive development, a new randomised, controlled trial has concluded.
September 7, 2023
In a report issued this week, Novozymes OneHealth shared current consumer perspectives and trends to help dietary supplement companies meet evolving needs in a fast-growing mental wellness market.
September 7, 2023
Exposure to an infant formula mimicking human milk lipid composition and milk fat globule structure positively affects child neurocognitive development, a new randomised, controlled trial has concluded.
September 6, 2023
Researchers explore available evidence that medicinal plants may help improve cognitive function by reducing brain inflammation.
September 6, 2023
There's consumer demand and innovation avenues in abundance when it comes to food and drink for cognitive health but brands must educate on the more novel ingredients if these are to flourish beyond the niche audience, Mintel experts advise.
September 6, 2023
In a report issued this week, Novozymes OneHealth shared current consumer perspectives and trends to help dietary supplement companies meet evolving needs in a fast-growing mental wellness market.
September 5, 2023
The 63-patient study was designed to monitor the intensity of pain in patients who had long COVID and administered either the drug, TNX-102 SL, or placebo, but the trial failed to show improvement at week 14 of treatment, the company said. However, the study showed that the drug helped reduce fatigue and improve sleep quality and cognitive function in the patients, the company said. Tonix intends to meet officials from the U.S. Food and Drug Administration in early 2024 to seek permission to c...
September 4, 2023
Researchers explored the biology of cognitive deficits following acute COVID-19.